4.6 Article

Carbon Fiber/Polyether Ether Ketone (CF/PEEK) Implants Allow for More Effective Radiation in Long Bones

期刊

MATERIALS
卷 13, 期 7, 页码 -

出版社

MDPI
DOI: 10.3390/ma13071754

关键词

bone metastasis; orthopedic oncology; carbon fiber polyether ether ketone; radiation therapy; imaging artefact; dose deviation

向作者/读者索取更多资源

Background: Metallic implants show dose-modulating effects in radiotherapy and complicate its computed tomography (CT)-based planning. Dose deviations might not only affect the surrounding tissues due to backscattering and inadvertent dose increase but might also compromise the therapeutic effect to the target lesion due to beam attenuation. Later on, follow-up imaging is often obscured by metallic artefacts. Purposes: This study investigates the dosimetric impact of titanium and radiolucent carbon fiber/polyether ether ketone (CF/PEEK) implants during adjuvant radiation therapy in long bones. (1) Does the use of CF/PEEK implants allow for a more homogenous application of radiation? (2) Is the dose delivery to the target volume more efficient when using CF/PEEK implants? (3) Do CF/PEEK implants facilitate CT-based radiation therapy planning? Materials and methods: After CT-based planning, bone models of six ovine femora were irradiated within a water phantom in two immersion depths to simulate different soft-tissue envelopes. Plates and intramedullary nails of both titanium and CF/PEEK were investigated. Radiation dosage and distribution patterns were mapped using dosimetry films. Results: First, the planned implant-related beam attenuation was lower for the CF/PEEK plate (1% vs. 5%) and the CF/PEEK nail (2% vs. 9%) than for corresponding titanium implants. Secondly, the effective decrease of radiation dosage behind the implants was noticeably smaller when using CF/PEEK implants. The radiation dose was not significantly affected by the amount of surrounding soft tissues. A significant imaging artefact reduction was seen in all CF/PEEK models. Conclusion: CF/PEEK implants lead to a more reliable and more effective delivery of radiation dose to an osseous target volume. With regard to radiation therapy, the use of CF/PEEK implants appears to be particularly beneficial for intramedullary nails.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial

Marcus Beck, Manfred Sassowsky, Sami Schaer, Etienne Mathier, Matthias Halter, Daniel R. Zwahlen, Tobias Hoelscher, Winfried Arnold, Bulent Polat, Guido Hildebrandt, Arndt-Christian Mueller, Paul M. Putora, Alexandros Papachristofilou, Stefanie Hayoz, Corinne Schaer, Qiyu Li, Marcin Sumila, Kathrin Zaugg, Matthias Guckenberger, Piet Ost, Davide G. Bosetti, Christiane Reuter, Silvia Gomez, Kaouthar Khanfir, Daniel M. Aebersold, Pirus Ghadjar, Alan Dal Pra

Summary: This study evaluated the results of a radiation therapy quality assurance program in patients with biochemically recurrent prostate cancer after prostatectomy. The study found that there were significant deviations from the treatment protocol guidelines and recommendations, which were associated with an increased risk of acute or late gastrointestinal or genitourinary toxicity and a trend towards worse freedom from biochemical progression (FFBP).

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Oncology

MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)

M. Pavic, M. Niyazi, L. Wilke, S. Corradini, M. Vornhuelz, U. Mansmann, A. Al Tawil, R. Fritsch, J. Hoerner-Rieber, J. Debus, M. Guckenberger, C. Belka, J. Mayerle, G. Beyer

Summary: This study aims to investigate the impact of SBRT on pain control in patients with mPDAC by embedding MR-guided adaptive SBRT of the pPca in between standard chemotherapy cycles. A total of 92 eligible patients will be enrolled in a randomized controlled trial across 3 centers in Germany and Switzerland to evaluate the added benefit of MR-guided SBRT for pain control and prevention.

RADIATION ONCOLOGY (2022)

Article Oncology

Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial

J. Ristau, J. Hoerner-Rieber, C. Buchele, S. Klueter, C. Jaekel, L. Baumann, N. Andratschke, H. Garcia Schueler, M. Guckenberger, M. Li, M. Niyazi, C. Belka, K. Herfarth, J. Debus, S. A. Koerber

Summary: This study aims to evaluate the safety and feasibility of MRI-guided stereotactic radiotherapy for localized prostate cancer. Moderate hypofractionation has become the standard treatment for prostate cancer, and ultrahypofractionation may further reduce treatment time. MRI-guided radiotherapy can avoid invasive procedures and, combined with gating and plan adaptation, can improve treatment effectiveness and reduce toxicity.

RADIATION ONCOLOGY (2022)

Article Oncology

Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer

Willem J. A. Witlox, Bram L. T. Ramaekers, Benjamin Lacas, Cecile Le Pechoux, Alexander Sun, Si-Yu Wang, Chen Hu, Mary Redman, Vincent van der Noort, Ning Li, Matthias Guckenberger, Harm van Tinteren, Lizza E. L. Hendriks, Harry J. M. Groen, Manuela A. Joore, Dirk K. M. De Ruysscher

Summary: This study assessed the cost-effectiveness of prophylactic cranial irradiation (PCI) compared to no PCI in stage III non-small cell lung cancer (NSCLC) from a Dutch societal perspective. The findings indicate that PCI is cost-effective compared to no PCI at a willingness-to-pay threshold of 80,000 per quality-adjusted life year (QALY).

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Incidence and survival of patients with oligometastatic esophagogastric cancer: A multicenter cohort study

Tiuri E. Kroese, Sebastian M. Christ, Peter S. N. van Rossum, Matthijs D. L. Burger, George S. Buijs, Urs Muhlematter, Nicolaus Andratschke, Jelle P. Ruurda, Martin Hullner, Christian A. Gutschow, Richard van Hillegersberg, Matthias Guckenberger

Summary: This multicenter study assessed the incidence and survival of patients with esophagogastric cancer and oligometastatic disease (OMD) in two tertiary referral cancer centers in The Netherlands and Switzerland. The study found that local treatment plus systemic therapy was associated with improved overall survival compared to systemic therapy alone.

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung

Therese MJ. Kang, Nicholas Hardcastle, Anurag K. Singh, Ben J. Slotman, Gregory M. M. Videtic, Kevin L. Stephans, Felipe Coun Counago, Alexander V. Louie, Matthias Guckenberger, Susan V. Harden, Nikki M. Plumridge, Shankar Siva

Summary: SABR is an effective treatment for inoperable early-stage NSCLC and pulmonary oligometastases. Single-fraction SABR, with its excellent local control and safety profiles, has advantages in terms of resource efficiency and reduced hospital visits, especially during the COVID-19 pandemic.

LUNG CANCER (2022)

Article Oncology

An ESTRO-ACROP guideline on quality assurance and medical physics commissioning of online MRI guided radiotherapy systems based on a consensus expert opinion

Stephanie Tanadini-Lang, Geoff Budgell, Omar Bohoudi, Stefanie Corradini, Davide Cusumano, Gorkem Gungor, Linda G. W. Kerkmeijer, Faisal Mahmood, Simeon Nill, Miguel A. Palacios, Michael Reiner, Daniela Thorwarth, Lotte Wilke, Jochem Wolthaus

Summary: The objective of this study was to define QA tests for oMRgRT systems and to identify important medical physics aspects for installation and commissioning. Twenty-four potentially important QA tests were identified, along with eleven tasks and aspects related to construction, workflow development, and training. A program for QA and commissioning of oMRgRT systems was developed to support safe handling of such systems.

RADIOTHERAPY AND ONCOLOGY (2023)

Article Medicine, Research & Experimental

Study protocol: short against long antibiotic therapy for infected orthopedic sites - the randomized-controlled SALATIO trials

Ilker Uckay, Stephan Wirth, Bjoern Zoerner, Sandro Fucentese, Karl Wieser, Andreas Schweizer, Daniel Mueller, Patrick Zingg, Mazda Farshad

Summary: In order to reduce antibiotic use and associated adverse events, we conducted two similar randomized controlled trials to explore the appropriate duration of post-surgical antibiotic therapy for orthopedic infections. The primary outcomes were remission and microbiologically-identical recurrences, while the main secondary outcome was antibiotic-related adverse events.

TRIALS (2023)

Article Oncology

Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer

Mireille Conrad, Riccardo Dal Bello, Janita E. van Timmeren, Nicolaus Andratschke, Lotte Wilke, Matthias Guckenberger, Stephanie Tanadini-Lang, Panagiotis Balermpas

Summary: This study compares the effect of MR-guided radiotherapy and conventional radiotherapy on the surface dose of head and neck cancer patients, and finds that using MR-linac can effectively cover superficial tissue and reduce side effects.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Meeting Abstract Oncology

Gating has small impact on dose to OARs and PTV coverage in MR-guided daily ART of prostate cancer

I. Wahlstedt, N. Andratschke, C. P. Behrens, S. Ehrbar, H. S. Gabrys, H. Garcia Schueler, M. Guckenberger, A. G. Smith, S. Tanadini-Lang, J. D. Tascon-Vidarte, I. R. Vogelius, J. E. van Timmeren

RADIOTHERAPY AND ONCOLOGY (2022)

Meeting Abstract Oncology

Comparison of methods for T1-w brain MRI intensity normalization for quantitative MRI analysis

P. Wallimann, M. Mayinger, M. Bogowicz, M. Guckenberger, N. Andratschke, S. Tanadini-Lang, J. E. van Timmeren

RADIOTHERAPY AND ONCOLOGY (2022)

Meeting Abstract Oncology

Systemic Therapy-Free Survival after Stereotactic Body Radiotherapy for Oligorecurrent Disease

J. Willmann, E. Vlaskou Badra, S. Adilovic, J. E. van Timmeren, M. Mayinger, M. Guckenberger, N. Andratschke

RADIOTHERAPY AND ONCOLOGY (2022)

Article Oncology

Prospective assessment of stress and health concerns of radiation oncology staff during the COVID-19 pandemic

Sebastian M. Christ, Michael Denner, Nicolaus Andratschke, Panagiotis Balermpas, Brigitte Hilty, Stephanie Tanadini-Lang, Lotte Wilke, Sophie Perryck, Matthias Guckenberger

Summary: During the first year of the COVID-19 pandemic, weekly online surveys were conducted to monitor stress levels and health concerns among employees in a radiation oncology department. The surveys were found to be feasible and valuable in identifying profession and workplace specific stress patterns and guiding tailored interventions.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2022)

Article Oncology

Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study

Natalia Saltybaeva, Stephanie Tanadini-Lang, Diem Vuong, Simon Burgermeister, Michael Mayinger, Andrea Bink, Nicolaus Andratschke, Matthias Guckenberger, Marta Bogowicz

Summary: The study showed that different image normalization methods have varying effects on the stability of radiomic features, with histogram matching based on the tumor region being the most stable. Histogram matching also improved the prognostic value of the images, which is significant for multicenter studies.

PHYSICS & IMAGING IN RADIATION ONCOLOGY (2022)

Meeting Abstract Oncology

Development and external Validation of an MRI-based Neural Network for the Segmentation of Brain Metastases in the AURORA Multicenter Study

J. A. Buchner, F. Kofler, M. Mayinger, T. Brunner, A. Wittig, B. Menze, C. Zimmer, B. Meyer, M. Guckenberger, N. Andratschke, R. A. E. Shafie, J. Peter Debus, S. Rogers, O. Riesterer, K. Schulze, H. J. Feldmann, O. Blanck, C. Zamboglou, K. Ferentinos, K. A. Eitz, S. Combs, D. Bernhardt, B. Wiestler, J. Peeken

STRAHLENTHERAPIE UND ONKOLOGIE (2022)

暂无数据